Guidelines
Definition and assessment of high risk in patients considered for lobectomy for stage I non–small cell lung cancer: The American Association for Thoracic Surgery expert panel consensus document
Lobectomy is a standard treatment for stage I non–small cell lung cancer, but a significant proportion of patients are considered at high risk for complications, including mortality, after lobectomy and might not be candidates. Identifying who is at risk is important and in evolution. The objective of The American Association for Thoracic Surgery Clinical Practice Standards Committee expert panel was to review important considerations and factors in assessing who is at high risk among patients considered for lobectomy.2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure
It is estimated that more than 125 million people live with ischemic heart disease globally, and each year in the United States, 720,000 have a first myocardial infarction resulting in hospital admission or death.1,2 Approximately 35% of those who experience a coronary event in a given year die because of it, and each death is associated with an average of 16 years of life lost. Ischemic cardiomyopathy (ICM) is the single largest cause of heart failure (HF), although the underlying causes are often multifactorial and overlapping.2021 The American Association for Thoracic Surgery expert consensus document: Surgical treatment of acute type A aortic dissection
Acute aortic dissection (AD) involves the ascending aorta in approximately two-thirds of patients.1,2 Chest pain is the most common feature, but clinical presentation can be varied, and algorithms have been developed to facilitate timely diagnosis.3,4 Nevertheless, delays in diagnosis comes at a severe cost to the patient.5 The complications of AD that involve the ascending aorta have been known for well over 60 years and include aortic rupture, cardiac tamponade, aortic regurgitation (AR), and organ malperfusion.The American Association for Thoracic Surgery Congenital Cardiac Surgery Working Group 2021 consensus document on a comprehensive perioperative approach to enhanced recovery after pediatric cardiac surgery
Components of enhanced recovery programs (ERPs) for pediatric cardiac surgery across the perioperative period.2016 update to The American Association for Thoracic Surgery (AATS) consensus guidelines: Ischemic mitral valve regurgitation
The objective of this project was to provide an update to the previously published consensus 2015 The American Association for Thoracic Surgery (AATS) evidence-based guidelines for the management of ischemic mitral regurgitation (IMR).The American Association for Thoracic Surgery consensus guidelines for the management of empyema
The study objective was to establish The American Association for Thoracic Surgery (AATS) evidence-based guidelines for the management of empyema.2016 The American Association for Thoracic Surgery (AATS) consensus guidelines: Surgical treatment of infective endocarditis: Executive summary
Our mission was to develop evidence-based American Association for Thoracic Surgery (AATS) consensus focused on the surgical treatment of infective endocarditis (IE) and perioperative questions: when to operate, how to prepare the patient for operation, how to operate, and other issues relevant to managing and following patients after surgery.1-8 The writing committee included 4 cardiac surgeons, 1 cardiologist, 2 infectious disease specialists, and Dr Eugene H. Blackstone. The draft produced was reviewed by invited additional experts, including 4 cardiac surgeons, 1 anesthesiologist, 1 cardiologist, 2 imaging experts, 3 infectious disease specialists, and 1 neurologist (See Appendix E1).2015 The American Association for Thoracic Surgery Consensus Guidelines: Ischemic mitral valve regurgitation
The objective of this project was to establish consensus 2015 The American Association for Thoracic Surgery (AATS) evidence-based guidelines for the management of ischemic mitral regurgitation (IMR).The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups
Lung cancer is the leading cause of cancer death in North America. Low-dose computed tomography screening can reduce lung cancer–specific mortality by 20%.
